Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
PUNE, India, April 19, 2024 /PRNewswire/ -- The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $33.06 billion in 2023 to reach $57.97 billion by 2030, at a CAGR of 8.35% over the forecast period.
"Advancements in Peptide Therapeutics Fueling Global Innovations in Disease Treatment"
Peptide therapeutics are emerging as a powerful approach to combat various diseases, owing to their ability to utilize short chains of amino acids to effectively target and treat health conditions. With the prevalence of chronic diseases such as cancer and diabetes, the need for innovative treatments is more significant than ever, highlighting the importance of exploring protein interactions for targeted therapeutic strategies. Challenges include the instability of peptides and the hefty cost of production; the field is witnessing a surge in research and development efforts. This push is prompted by a growing clinical pipeline filled with promising therapeutic candidates, pointing toward an era of advanced peptide-based treatments. The Americas are backed by a solid pharmaceutical foundation and increased peptide drug approvals, whereas the Asia-Pacific region is rapidly growing, driven by escalating chronic disease cases, improved healthcare infrastructure, and heightened awareness of peptide therapeutics. Europe and the Middle East continue to support innovation through favorable regulatory policies and significant investment in research, exhibiting the global market's potential to revolutionize healthcare with peptide therapeutics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
"The Rising Influence of Peptide Therapeutics on Non-Surgical Treatments"
Aesthetic dermatology has significantly evolved, with peptide therapeutics at the forefront of this transformation. These innovative treatments, particularly signal peptides, are pivotal in promoting skin collagen production by transitioning toward this shift of molecular-based cosmetic enhancements. This advancement is crucial in enhancing skin firmness while minimizing wrinkles, marking a deviation from traditional, more invasive procedures. Peptides have become integral to topical applications such as creams, serums, and gels, addressing anti-aging concerns, improving skin hydration, and facilitating barrier repair. Furthermore, their synergy with other dermatological techniques, including chemical peels and microdermabrasion, accelerates healing and fosters skin rejuvenation. Amidst rising achievements in the field, the industry is witnessing substantial investments to boost peptide production for dermatological purposes, emphasizing the vital role of peptides in improving non-surgical treatment outcomes and developing new approaches in patient care within aesthetic dermatology.
"Innovative Hybrid Phase Approach Revolutionizes Complex Peptide Synthesis"
The cutting-edge hybrid phase approach is transforming the field of peptide therapeutics by ingeniously merging liquid-phase and solid-phase synthesis. This groundbreaking method proves superior, especially when crafting large or intricate peptides, by addressing the limitations inherent in traditional synthesis strategies. While liquid-phase peptide synthesis (LPPS) produces small to medium peptides on a small scale, its solid-phase counterpart assembles longer, more complicated peptide sequences with remarkable efficiency and scalability. The hybrid phase technology is flexible, incorporating the rapidity of liquid-phase techniques in the initial stages and the robustness of solid-phase methods for crafting larger, complex structures. This approach enhances the production efficiency and scalability of peptide synthesis and ensures the high purity of the final peptides, making it crucial for researchers and industries focused on developing next-generation peptide therapeutics.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
"Novo Nordisk A/S at the Forefront of Peptide Therapeutics Market with a Strong 7.12% Market Share"
The key players in the Peptide Therapeutics Market include AstraZeneca PLC, Novo Nordisk A/S, Ipsen Group, GlaxoSmithKline PLC, Eli Lilly and Company, and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
"Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Peptide Therapeutics Market"
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Peptide Therapeutics Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Peptide Therapeutics Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/peptide-therapeutics
"Dive into the Peptide Therapeutics Market Landscape: Explore 194 Pages of Insights, 566 Tables, and 28 Figures"
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Peptide Therapeutics Market, by Technology
- Peptide Therapeutics Market, by Drug Class
- Peptide Therapeutics Market, by Route of Administration
- Peptide Therapeutics Market, by Application
- Peptide Therapeutics Market, by End User
- Peptide Therapeutics Market, by Manufacturing Type
- Americas Peptide Therapeutics Market
- Asia-Pacific Peptide Therapeutics Market
- Europe, Middle East & Africa Peptide Therapeutics Market
- Competitive Landscape
- Competitive Portfolio
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
Related Reports:
- Constrained Peptide Drugs Market - Global Forecast 2024-2030
- Oral Proteins & Peptides Market - Global Forecast 2024-2030
- Peptide Antibiotics Market - Global Forecast 2024-2030
About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearch
Mr. Ketan Rohom
360iResearch Private Limited,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
Email: sales@360iresearch.com
USA: +1-530-264-8485
India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo: https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
Share this article